AGIOS PHARMACEUTICALS INC's ticker is and the CUSIP is 00847X904. A total of 4 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $317,184 | -62.8% | 11,200 | -69.8% | 0.00% | – |
| Q1 2023 | $852,187 | -66.7% | 37,100 | -59.3% | 0.00% | -100.0% |
| Q4 2022 | $2,558,088 | +63.2% | 91,100 | +64.4% | 0.00% | 0.0% |
| Q3 2022 | $1,567,000 | +2.3% | 55,400 | -19.8% | 0.00% | 0.0% |
| Q2 2022 | $1,532,000 | – | 69,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 168 | $284,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 11,900 | $1,333,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 32 | $359,000 | 0.01% |
| Citadel Advisors | 69,900 | $7,832,000 | 0.01% |